A Phase III Study of IPD-1151T in Patients With Interstitial Cystitis
Phase 3
- Conditions
- Interstitial cystitis
- Registration Number
- JPRN-jRCT2080220253
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1)20 years and older
2)Interstitial cystitis-characteristic findings observed by cystoscope under
hydrodistension
3)Stable for 12 weeks and more following hydrodistension of the bladder
4)IC symptom score of 7 and higher at the end of 2-week observation period
5)Pain score including bladder pain of 4 and higher
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of IC symptom score and incidence of adverse drug reactions
- Secondary Outcome Measures
Name Time Method